---
title: "Chinese Pharma Experts Discuss Innovative Drugs’ Full Chain From R&D to Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295064772.md"
description: "(Yicai) Aug. 6 -- This episode of Growth Tech Talks focuses on high-quality development and global breakthroughs in the innovative pharmaceutical industry, exploring the full chain of innovative drug R&D, clinical trials, CRO services, and commercialization. It features guests including RemeGen’s Chairman Wang Weidong, InnoCare Pharma’s Chairwoman and CEO Jasmine Cui, Dizal Pharmaceutical’s Chair and CEO Zhang Xiaolin, Shanghai Medicilon’s Chair and CEO Chen Chunlin, and Guotai Haitong Securities’ Chief Flobal Healthcare Analyst Yu Wenxin."
datetime: "2026-08-06T06:33:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295064772.md)
  - [en](https://longbridge.com/en/news/295064772.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295064772.md)
---

# Chinese Pharma Experts Discuss Innovative Drugs’ Full Chain From R&D to Market

(Yicai) Aug. 6 -- This episode of Growth Tech Talks focuses on high-quality development and global breakthroughs in the innovative pharmaceutical industry, exploring the full chain of innovative drug R&D, clinical trials, CRO services, and commercialization. It features guests including RemeGen’s Chairman Wang Weidong, InnoCare Pharma’s Chairwoman and CEO Jasmine Cui, Dizal Pharmaceutical’s Chair and CEO Zhang Xiaolin, Shanghai Medicilon’s Chair and CEO Chen Chunlin, and Guotai Haitong Securities’ Chief Flobal Healthcare Analyst Yu Wenxin.

### Related Stocks

- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)
- [688192.CN](https://longbridge.com/en/quote/688192.CN.md)
- [688202.CN](https://longbridge.com/en/quote/688202.CN.md)
- [688331.CN](https://longbridge.com/en/quote/688331.CN.md)
- [09969.HK](https://longbridge.com/en/quote/09969.HK.md)
- [688428.CN](https://longbridge.com/en/quote/688428.CN.md)

## Related News & Research

- [J.P. Morgan Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)](https://longbridge.com/en/news/295287684.md)
- [RemeGen Forecasts Major Profit Turnaround on Surging Drug Sales and AbbVie Licensing Deal](https://longbridge.com/en/news/294974949.md)
- [03:00 ETCan Independent Critical Access Hospitals Solve the Rural Healthcare Crisis? "All Access hosted by Andy Garcia" Features Syracuse Area Health](https://longbridge.com/en/news/296188096.md)
- [GUBRA: Biotech revenue normalized post-AbbVie deal; CRO rebounded with 11% growth and profitability](https://longbridge.com/en/news/296439475.md)
- [ABC’s livestreamed news show is powered by trending topics](https://longbridge.com/en/news/296146356.md)